349 related articles for article (PubMed ID: 25009381)
1. Metabolomic studies of human gastric cancer: review.
Jayavelu ND; Bar NS
World J Gastroenterol; 2014 Jul; 20(25):8092-101. PubMed ID: 25009381
[TBL] [Abstract][Full Text] [Related]
2. Glucose metabolism in gastric cancer: The cutting-edge.
Yuan LW; Yamashita H; Seto Y
World J Gastroenterol; 2016 Feb; 22(6):2046-59. PubMed ID: 26877609
[TBL] [Abstract][Full Text] [Related]
3. Gastric cancer: Metabolic and metabolomics perspectives (Review).
Xiao S; Zhou L
Int J Oncol; 2017 Jul; 51(1):5-17. PubMed ID: 28535006
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of metabolomics in oncology: a review.
Spratlin JL; Serkova NJ; Eckhardt SG
Clin Cancer Res; 2009 Jan; 15(2):431-40. PubMed ID: 19147747
[TBL] [Abstract][Full Text] [Related]
5. Potential role of metabolomics in diagnosis and surveillance of gastric cancer.
Chan AW; Gill RS; Schiller D; Sawyer MB
World J Gastroenterol; 2014 Sep; 20(36):12874-82. PubMed ID: 25278684
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic profiling of oesophago-gastric cancer: a systematic review.
Abbassi-Ghadi N; Kumar S; Huang J; Goldin R; Takats Z; Hanna GB
Eur J Cancer; 2013 Nov; 49(17):3625-37. PubMed ID: 23896378
[TBL] [Abstract][Full Text] [Related]
8. Proteomic and metabolic prediction of response to therapy in gastric cancer.
Aichler M; Luber B; Lordick F; Walch A
World J Gastroenterol; 2014 Oct; 20(38):13648-57. PubMed ID: 25320503
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry.
Wu H; Xue R; Tang Z; Deng C; Liu T; Zeng H; Sun Y; Shen X
Anal Bioanal Chem; 2010 Feb; 396(4):1385-95. PubMed ID: 20012946
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry.
Chen JL; Tang HQ; Hu JD; Fan J; Hong J; Gu JZ
World J Gastroenterol; 2010 Dec; 16(46):5874-80. PubMed ID: 21155010
[TBL] [Abstract][Full Text] [Related]
12. A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer.
Wang X; Yan SK; Dai WX; Liu XR; Zhang WD; Wang JJ
Int J Cancer; 2010 Dec; 127(12):2841-50. PubMed ID: 21351263
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
[TBL] [Abstract][Full Text] [Related]
14. Contactin 1: A potential therapeutic target and biomarker in gastric cancer.
Chen DH; Yu JW; Jiang BJ
World J Gastroenterol; 2015 Sep; 21(33):9707-16. PubMed ID: 26361417
[TBL] [Abstract][Full Text] [Related]
15. The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice.
Abbas M; Habib M; Naveed M; Karthik K; Dhama K; Shi M; Dingding C
Biomed Pharmacother; 2017 Nov; 95():1082-1090. PubMed ID: 28922727
[TBL] [Abstract][Full Text] [Related]
16. Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS.
Hu JD; Tang HQ; Zhang Q; Fan J; Hong J; Gu JZ; Chen JL
World J Gastroenterol; 2011 Feb; 17(6):727-34. PubMed ID: 21390142
[TBL] [Abstract][Full Text] [Related]
17. Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
Wang H; Zhang H; Deng P; Liu C; Li D; Jie H; Zhang H; Zhou Z; Zhao YL
BMC Cancer; 2016 Jun; 16():371. PubMed ID: 27356757
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics profile in gastrointestinal cancers: Update and future perspectives.
Nannini G; Meoni G; Amedei A; Tenori L
World J Gastroenterol; 2020 May; 26(20):2514-2532. PubMed ID: 32523308
[TBL] [Abstract][Full Text] [Related]
19. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
